Skip to main content

04-04-2018 | Psoriatic arthritis | Article

Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: Results of the randomized, placebo-controlled PALACE 4 trial

Wells AF et al. Rheumatology (Oxford) 2018; Advance online publication. doi: 10.1093/rheumatology/key032

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics